---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-066904"
form_type: "8-K"
ticker: "EMMA"
cik: "0000822370"
company_name: "Emmaus Life Sciences, Inc."
filed_at: "2023-08-14T23:59:59+00:00"
generated_at: "2026-06-11T13:30:17.219292+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Emmaus Life Sciences reports record Q2 net revenue of $10.8M; posts $3.3M income from operations

## Summary
- Q2 net revenue $10.8M (up 151% YoY); six-month net revenue $17.5M (up 133% YoY).
- Q2 income from operations $3.3M vs loss of $1.4M in Q2 2022; six-month income $2.2M vs loss of $4.5M.
- Net loss narrowed to $1.5M ($0.03/sh) from $8.9M ($0.18/sh) in Q2 2022; six-month loss $5.0M ($0.10) vs $10.4M ($0.21).
- Sales growth driven by $4.1M increase in MENA region in Q2; U.S. sales also recovering.
- Cash and equivalents $1.4M at June 30, 2023, down from $2.0M at Dec 31, 2022.

## SEC filing metadata
- accession: 0001213900-23-066904
- form_type: 8-K
- ticker: EMMA
- cik: 0000822370
- company_name: Emmaus Life Sciences, Inc.
- filed_at: 2023-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/822370/000121390023066904/0001213900-23-066904-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/822370/000121390023066904/ea183077-8k_emmaus.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-066904
- JSON: https://secwatch.observer/filing/0001213900-23-066904.json
- Plain text: https://secwatch.observer/filing/0001213900-23-066904.txt

## Key facts
- Earnings Releases
  Emmaus Life Sciences, Inc. reported three and six months ended June 30, 2023 results: revenue $10.8 million and $17.5 million, net income net loss of $1.5 million, or $0.03 per share, EPS $0.03 per share.
  - Period: three and six months ended June 30, 2023
  - Revenue: $10.8 million and $17.5 million
  - Net income: net loss of $1.5 million, or $0.03 per share
  - EPS: $0.03 per share
  - Result: reported results
  source text: Net revenues for the three months and six months ended June 30, 2023 were $10.8 million and $17.5 million, respectively
  evidence_url: https://www.sec.gov/Archives/edgar/data/822370/000121390023066904/0001213900-23-066904-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.